Mehta N - Search Results

1

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Mehta N, et al. Int J Oncol. 2004 Dec;25(6):1677-83. Int J Oncol. 2004. PMID: 15547705 Clinical Trial.

2

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.

Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Haraf DJ, Hellman S, Weichselbaum RR. Salama JK, et al. Among authors: mehta n. Clin Cancer Res. 2008 Aug 15;14(16):5255-9. doi: 10.1158/1078-0432.CCR-08-0358. Clin Cancer Res. 2008. PMID: 18698045 Clinical Trial.

3

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.

Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, Villaflor VM, Stadler WM, Hoffman PC, Cohen EE, Connell PP, Haraf DJ, Vokes EE, Hellman S, Weichselbaum RR. Salama JK, et al. Among authors: mehta n. Cancer. 2012 Jun 1;118(11):2962-70. doi: 10.1002/cncr.26611. Epub 2011 Oct 21. Cancer. 2012. PMID: 22020702 Free article. Clinical Trial.

4

Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity.

Lopez CA, Kimchi ET, Mauceri HJ, Park JO, Mehta N, Murphy KT, Beckett MA, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Lopez CA, et al. Among authors: mehta n. Mol Cancer Ther. 2004 Sep;3(9):1167-75. Mol Cancer Ther. 2004. PMID: 15367711

5

Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.

Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ. Murphy KT, et al. Among authors: mehta n. Cancer Chemother Pharmacol. 2005 Sep;56(3):317-21. doi: 10.1007/s00280-004-0986-8. Epub 2005 May 11. Cancer Chemother Pharmacol. 2005. PMID: 15887016

6

Sequential chemoimmunotherapy in the treatment of metastatic melanoma.

Richards JM, Mehta N, Ramming K, Skosey P. Richards JM, et al. Among authors: mehta n. J Clin Oncol. 1992 Aug;10(8):1338-43. doi: 10.1200/JCO.1992.10.8.1338. J Clin Oncol. 1992. PMID: 1634924 Clinical Trial.

7

Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy.

Mehta N, Yamada SD, Rotmensch J, Mundt AJ. Mehta N, et al. Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):1004-9. doi: 10.1016/s0360-3016(03)00753-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 14575831

8

Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.

Citron JR, Sutton H, Yamada SD, Mehta N, Mundt AJ. Citron JR, et al. Among authors: mehta n. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1432-8. doi: 10.1016/j.ijrobp.2004.01.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275729

9

Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanoma.

Richards JM, Gale D, Mehta N, Lestingi T. Richards JM, et al. Among authors: mehta n. J Clin Oncol. 1999 Feb;17(2):651-7. doi: 10.1200/JCO.1999.17.2.651. J Clin Oncol. 1999. PMID: 10080611 Clinical Trial.

10

Preliminary outcome and toxicity report of extended-field, intensity-modulated radiation therapy for gynecologic malignancies.

Salama JK, Mundt AJ, Roeske J, Mehta N. Salama JK, et al. Among authors: mehta n. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1170-6. doi: 10.1016/j.ijrobp.2006.02.041. Epub 2006 May 26. Int J Radiat Oncol Biol Phys. 2006. PMID: 16730136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,779 results

Search Page

Filters